Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S-transferase A4.
Bo ChengXiaoliang HongLinfang WangYuanyuan CaoDengli QinHan ZhouDian-Shuai GaoPublished in: CNS neuroscience & therapeutics (2022)
In conclusion, inhibition of GSTA4 correlates with positive outcomes in glioma models, and thus, this molecule is a candidate drug for the treatment of glioma.